NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,098 | -12.9% | 154 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 154 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -36.4% | 154 | 0.0% | 0.00% | – |
| Q1 2022 | $11,000 | -8.3% | 154 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -33.3% | 154 | 0.0% | 0.00% | – |
| Q3 2021 | $18,000 | -30.8% | 154 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | +23.8% | 154 | 0.0% | 0.00% | – |
| Q1 2021 | $21,000 | -19.2% | 154 | +4.1% | 0.00% | – |
| Q4 2020 | $26,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |